138 related articles for article (PubMed ID: 29210673)
1. Detecting beta-amyloid aggregation from time-resolved emission spectra.
Alghamdi A; Vyshemirsky V; Birch DJS; Rolinski OJ
Methods Appl Fluoresc; 2018 Jan; 6(2):024002. PubMed ID: 29210673
[TBL] [Abstract][Full Text] [Related]
2. Beta-amyloid oligomerisation monitored by intrinsic tyrosine fluorescence.
Amaro M; Birch DJ; Rolinski OJ
Phys Chem Chem Phys; 2011 Apr; 13(14):6434-41. PubMed ID: 21373703
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine Photophysics During the Early Stages of β-Amyloid Aggregation Leading to Alzheimer's.
Rolinski OJ; Wellbrock T; Birch DJ; Vyshemirsky V
J Phys Chem Lett; 2015 Aug; 6(15):3116-20. PubMed ID: 26267211
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Flavonoid Quercetin on β-Amyloid Aggregation Revealed by Intrinsic Fluorescence.
Alghamdi A; Birch DJS; Vyshemirsky V; Rolinski OJ
J Phys Chem B; 2022 Sep; 126(38):7229-7237. PubMed ID: 36121408
[TBL] [Abstract][Full Text] [Related]
5. Critical aggregation concentration for the formation of early Amyloid-β (1-42) oligomers.
Novo M; Freire S; Al-Soufi W
Sci Rep; 2018 Jan; 8(1):1783. PubMed ID: 29379133
[TBL] [Abstract][Full Text] [Related]
6. Detecting beta-amyloid glycation by intrinsic fluorescence - Understanding the link between diabetes and Alzheimer's disease.
Alghamdi A; Forbes S; Birch DJS; Vyshemirsky V; Rolinski OJ
Arch Biochem Biophys; 2021 Jun; 704():108886. PubMed ID: 33887256
[TBL] [Abstract][Full Text] [Related]
7. Cu
Alghamdi A; Wellbrock T; Birch DJS; Vyshemirsky V; Rolinski OJ
Chemphyschem; 2019 Dec; 20(23):3181-3185. PubMed ID: 31539190
[TBL] [Abstract][Full Text] [Related]
8. Aggregation States of A
Festa G; Mallamace F; Sancesario GM; Corsaro C; Mallamace D; Fazio E; Arcidiacono L; Garcia Sakai V; Senesi R; Preziosi E; Sancesario G; Andreani C
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450543
[TBL] [Abstract][Full Text] [Related]
9. High-resolution NMR characterization of low abundance oligomers of amyloid-β without purification.
Kotler SA; Brender JR; Vivekanandan S; Suzuki Y; Yamamoto K; Monette M; Krishnamoorthy J; Walsh P; Cauble M; Holl MM; Marsh EN; Ramamoorthy A
Sci Rep; 2015 Jul; 5():11811. PubMed ID: 26138908
[TBL] [Abstract][Full Text] [Related]
10. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
[TBL] [Abstract][Full Text] [Related]
11. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the aggregation processes of amyloid-β using a spin-labeled, fluorescent nitroxyl radical.
Mito F; Yamasaki T; Ito Y; Yamato M; Mino H; Sadasue H; Shirahama C; Sakai K; Utsumi H; Yamada K
Chem Commun (Camb); 2011 May; 47(17):5070-2. PubMed ID: 21442105
[TBL] [Abstract][Full Text] [Related]
13. Early detection of amyloid aggregation using intrinsic fluorescence.
Rolinski OJ; Amaro M; Birch DJ
Biosens Bioelectron; 2010 Jun; 25(10):2249-52. PubMed ID: 20362424
[TBL] [Abstract][Full Text] [Related]
14. Engineering of a peptide probe for β-amyloid aggregates.
Aoraha E; Candreva J; Kim JR
Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous measurement of a range of particle sizes during Aβ1-42 fibrillogenesis quantified using fluorescence correlation spectroscopy.
Mittag JJ; Milani S; Walsh DM; Rädler JO; McManus JJ
Biochem Biophys Res Commun; 2014 May; 448(2):195-9. PubMed ID: 24769478
[TBL] [Abstract][Full Text] [Related]
16. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
[TBL] [Abstract][Full Text] [Related]
17. [Physico-chemical methods for studing β-amyloid aggregation].
Radko SP; Khmeleva SA; Suprun EV; Kozin SA; Bodoev NV; Makarov AA; Archakov AI; Shumyantseva VV
Biomed Khim; 2015; 61(2):203-18. PubMed ID: 25978387
[TBL] [Abstract][Full Text] [Related]
18. Formation of oligomers in the early phase of pH-induced aggregation of the Alzheimer Aβ(12-28) peptide [corrected].
Mandal P; Eremina N; Barth A
J Phys Chem B; 2012 Oct; 116(41):12389-97. PubMed ID: 22978560
[TBL] [Abstract][Full Text] [Related]
19. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
20. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
